These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 19882014)

  • 21. The use of imiquimod 5% cream for the treatment of superficial basal cell carcinomas in a basal cell nevus syndrome patient.
    Kagy MK; Amonette R
    Dermatol Surg; 2000 Jun; 26(6):577-8; discussion 578-9. PubMed ID: 10848940
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Imiquimod: in superficial basal cell carcinoma.
    Oldfield V; Keating GM; Perry CM
    Am J Clin Dermatol; 2005; 6(3):195-200; discussion 201-2. PubMed ID: 15943496
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Superficial basal cell carcinoma on face treated with 5% imiquimod cream.
    Malhotra AK; Bansal A; Mridha AR; Khaitan BK; Verma KK
    Indian J Dermatol Venereol Leprol; 2006; 72(5):373-5. PubMed ID: 17050935
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Successful Treatment of Giant Basal Cell Carcinoma with Topical Imiquimod 5% Cream with Long Term Follow-up.
    Chun-Guang M; Qi-Man L; Yu-Yun Zh; Li-Hua Ch; Cheng T; Jian-De H
    Indian J Dermatol; 2014 Nov; 59(6):575-8. PubMed ID: 25484387
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Imiquimod 5% cream (Aldara) in the treatment of basal cell carcinoma.
    Sapijaszko MJ
    Skin Therapy Lett; 2005; 10(6):2-5. PubMed ID: 16292452
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Imiquimod 5% cream as adjunctive therapy for primary, solitary, nodular nasal basal cell carcinomas before Mohs micrographic surgery: a randomized, double blind, vehicle-controlled study.
    Butler DF; Parekh PK; Lenis A
    Dermatol Surg; 2009 Jan; 35(1):24-9. PubMed ID: 19018814
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pilot study of imiquimod 5% cream as adjunctive therapy to curettage and electrodesiccation for nodular basal cell carcinoma.
    Spencer JM
    Dermatol Surg; 2006 Jan; 32(1):63-9. PubMed ID: 16393600
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of imiquimod for the expression of Bcl-2, Ki67, p53 and basal cell carcinoma apoptosis.
    Vidal D; Matías-Guiu X; Alomar A
    Br J Dermatol; 2004 Sep; 151(3):656-62. PubMed ID: 15377354
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Imiquimod 5% cream as pretreatment of Mohs micrographic surgery for nodular basal cell carcinoma in the face: a prospective randomized controlled study.
    van der Geer S; Martens J; van Roij J; Brand E; Ostertag JU; Verhaegh ME; Neumann HA; Krekels GA
    Br J Dermatol; 2012 Jul; 167(1):110-5. PubMed ID: 22385074
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Imiquimod 5% as Adjuvant Therapy for Incompletely Excised Infiltrative Nodular Basal Cell Carcinoma and Dermoscopy to Monitor Treatment Response.
    Roldán-Marín R; Toussaint-Caire S
    Dermatol Ther (Heidelb); 2015 Dec; 5(4):265-272. PubMed ID: 26538104
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapeutic response of basal cell carcinoma to the immune response modifier imiquimod 5% cream.
    Beutner KR; Geisse JK; Helman D; Fox TL; Ginkel A; Owens ML
    J Am Acad Dermatol; 1999 Dec; 41(6):1002-7. PubMed ID: 10570388
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of all basal cell carcinoma variants including large and high-risk lesions with 5% imiquimod cream: histological and clinical changes, outcome, and follow-up.
    Schiessl C; Wolber C; Tauber M; Offner F; Strohal R
    J Drugs Dermatol; 2007 May; 6(5):507-13. PubMed ID: 17679185
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Surgical excision versus imiquimod 5% cream for nodular and superficial basal-cell carcinoma (SINS): a multicentre, non-inferiority, randomised controlled trial.
    Bath-Hextall F; Ozolins M; Armstrong SJ; Colver GB; Perkins W; Miller PS; Williams HC;
    Lancet Oncol; 2014 Jan; 15(1):96-105. PubMed ID: 24332516
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Management of patients with giant basal cell carcinoma during SARS COV2 outbreak in Italy.
    Cantisani C; Rossi R; Nisticò SP; Vitiello M; Farnetani F; Bennaro L; Pellacani G
    Transl Biophotonics; 2022 Aug; 4(3):e202200009. PubMed ID: 35942364
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Imiquimod: a review of basal cell carcinoma treatments.
    Karve SJ; Feldman SR; Yentzer BA; Pearce DJ; Balkrishnan R
    J Drugs Dermatol; 2008 Nov; 7(11):1044-51. PubMed ID: 19110735
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Superficial basal cell carcinoma treated with imiquimod 5% topical cream for a 4-week period: a case series.
    Ruiz-Villaverde R; Sánchez-Cano D; Burkhardt-Pérez P
    J Eur Acad Dermatol Venereol; 2009 Jul; 23(7):828-31. PubMed ID: 19646136
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reflectance Confocal Microscopy Follow-up of Multifocal Superficial Basal Cell Carcinomas Treated With Imiquimod 5% Cream.
    Zou Y; Zhu X; Xia R
    Dermatol Pract Concept; 2022 Nov; 12(4):e2022207. PubMed ID: 36534551
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: a single blind, non-inferiority, randomised controlled trial.
    Arits AH; Mosterd K; Essers BA; Spoorenberg E; Sommer A; De Rooij MJ; van Pelt HP; Quaedvlieg PJ; Krekels GA; van Neer PA; Rijzewijk JJ; van Geest AJ; Steijlen PM; Nelemans PJ; Kelleners-Smeets NW
    Lancet Oncol; 2013 Jun; 14(7):647-54. PubMed ID: 23683751
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pilot study using topical imiquimod 5% cream in the treatment of nodular basal cell carcinoma after initial treatment with curettage.
    Neville JA; Williford PM; Jorizzo JL
    J Drugs Dermatol; 2007 Sep; 6(9):910-4. PubMed ID: 17941362
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Imiquimod in basal cell carcinoma: how does it work?
    Dummer R; Urosevic M; Kempf W; Hoek K; Hafner J; Burg G
    Br J Dermatol; 2003 Nov; 149 Suppl 66():57-8. PubMed ID: 14616353
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.